$TTNP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TITAN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TITAN PHARMACEUTICALS INC. Get notifications about new insider transactions in TITAN PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 23 2007 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Executive VP and CO ... | Buy | P | 2.02 | 15,000 | 30,300 | 75,894 | 60.9 K to 75.9 K (+24.63 %) |
May 21 2007 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Executive VP and CO ... | Buy | P | 2.01 | 5,000 | 10,050 | 65,500 | 60.5 K to 65.5 K (+8.26 %) |
May 21 2007 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Executive VP and CO ... | Buy | P | 2.00 | 1,100 | 2,200 | 60,500 | 59.4 K to 60.5 K (+1.85 %) |
May 07 2007 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Buy | P | 2.29 | 1,000 | 2,290 | 550,000 | 549 K to 550 K (+0.18 %) |
May 07 2007 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Buy | P | 2.28 | 2,000 | 4,560 | 549,000 | 547 K to 549 K (+0.37 %) |
May 07 2007 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Buy | P | 2.27 | 10,000 | 22,700 | 547,000 | 537 K to 547 K (+1.86 %) |
May 07 2007 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Buy | P | 2.26 | 5,000 | 11,300 | 537,000 | 532 K to 537 K (+0.94 %) |
May 07 2007 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Buy | P | 2.25 | 4,800 | 10,800 | 532,000 | 527.2 K to 532 K (+0.91 %) |
May 07 2007 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Buy | P | 2.24 | 2,200 | 4,928 | 527,200 | 525 K to 527.2 K (+0.42 %) |
May 07 2007 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Buy | P | 2.50 | 17,000 | 42,500 | 525,000 | 508 K to 525 K (+3.35 %) |
May 07 2007 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Buy | P | 2.39 | 7,100 | 16,969 | 508,000 | 500.9 K to 508 K (+1.42 %) |
May 07 2007 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Buy | P | 2.38 | 900 | 2,142 | 500,900 | 500 K to 500.9 K (+0.18 %) |
Apr 30 2007 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Buy | P | 2.14 | 15,500 | 33,170 | 111,580 | 96.1 K to 111.6 K (+16.13 %) |
Mar 22 2007 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Buy | P | 2.40 | 18,400 | 44,160 | 96,080 | 77.7 K to 96.1 K (+23.69 %) |
Mar 22 2007 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Buy | P | 2.32 | 1,000 | 2,320 | 77,680 | 76.7 K to 77.7 K (+1.30 %) |
Mar 22 2007 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Buy | P | 2.30 | 100 | 230 | 76,680 | 76.6 K to 76.7 K (+0.13 %) |
Mar 22 2007 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Buy | P | 2.31 | 2,100 | 4,851 | 76,580 | 74.5 K to 76.6 K (+2.82 %) |
Mar 22 2007 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Buy | P | 2.34 | 4,000 | 9,360 | 74,480 | 70.5 K to 74.5 K (+5.68 %) |
Mar 22 2007 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Buy | P | 2.29 | 400 | 916 | 70,480 | 70.1 K to 70.5 K (+0.57 %) |
Jan 05 2007 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Option Exercise | A | 3.13 | 55,000 | 172,150 | 55,000 | |
Jan 05 2007 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Option Exercise | A | 3.13 | 115,000 | 359,950 | 115,000 | |
Jan 05 2007 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Executive VP and CO ... | Option Exercise | A | 3.13 | 80,000 | 250,400 | 80,000 | |
Sep 20 2006 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Option Exercise | A | 2.08 | 45,000 | 93,600 | 45,000 | |
Sep 07 2006 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Option Exercise | A | 2.48 | 5,000 | 12,400 | 5,000 | |
Sep 07 2006 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 2.48 | 10,000 | 24,800 | 10,000 | |
Sep 07 2006 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 2.48 | 15,000 | 37,200 | 15,000 | |
Sep 07 2006 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 2.48 | 15,000 | 37,200 | 15,000 | |
Sep 07 2006 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 2.48 | 15,000 | 37,200 | 15,000 | |
Sep 07 2006 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | A | 2.48 | 10,000 | 24,800 | 10,000 | |
Aug 31 2006 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Option Exercise | A | 2.35 | 20,000 | 47,000 | 20,000 | |
Aug 31 2006 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 2.35 | 20,000 | 47,000 | 20,000 | |
Aug 31 2006 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Option Exercise | A | 2.35 | 20,000 | 47,000 | 20,000 | |
Aug 31 2006 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 2.35 | 20,000 | 47,000 | 20,000 | |
Aug 31 2006 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Executive VP and CE ... | Option Exercise | A | 2.35 | 20,000 | 47,000 | 20,000 | |
Aug 31 2006 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Option Exercise | A | 2.35 | 20,000 | 47,000 | 20,000 | |
Aug 31 2006 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 2.35 | 20,000 | 47,000 | 20,000 | |
Aug 31 2006 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | A | 2.35 | 20,000 | 47,000 | 20,000 | |
Aug 31 2006 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 2.35 | 20,000 | 47,000 | 20,000 | |
Mar 14 2006 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | M | 1.71 | 5,000 | 8,550 | 0 | |
Mar 14 2006 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | M | 1.71 | 5,000 | 8,550 | 0 | |
Mar 14 2006 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | M | 1.71 | 13,125 | 22,444 | 0 | |
Mar 14 2006 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Buy | M | 1.71 | 5,000 | 8,550 | 58,699 | 53.7 K to 58.7 K (+9.31 %) |
Mar 14 2006 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Buy | M | 1.71 | 5,000 | 8,550 | 53,699 | 48.7 K to 53.7 K (+10.27 %) |
Mar 14 2006 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Buy | M | 1.71 | 13,125 | 22,444 | 48,699 | 35.6 K to 48.7 K (+36.89 %) |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 1.40 | 5,000 | 7,000 | 5,000 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec. VP & CFO | Option Exercise | A | 1.40 | 22,500 | 31,500 | 22,500 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec. VP & CFO | Option Exercise | A | 1.40 | 45,000 | 63,000 | 45,000 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 1.40 | 10,000 | 14,000 | 10,000 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | Pres. & Chief Exec. ... | Option Exercise | A | 1.40 | 100,000 | 140,000 | 100,000 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | Pres. & Chief Exec. ... | Option Exercise | A | 1.40 | 95,000 | 133,000 | 95,000 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | A | 1.40 | 10,000 | 14,000 | 10,000 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Option Exercise | A | 1.40 | 30,000 | 42,000 | 30,000 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Option Exercise | A | 1.40 | 27,000 | 37,800 | 27,000 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Option Exercise | A | 1.40 | 5,000 | 7,000 | 5,000 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 1.40 | 5,000 | 7,000 | 5,000 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Exec. V. P. and Chi ... | Option Exercise | A | 1.40 | 70,000 | 98,000 | 70,000 | |
Jan 05 2006 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Exec. V. P. and Chi ... | Option Exercise | A | 1.40 | 65,000 | 91,000 | 65,000 | |
Dec 07 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.33 | 13,500 | 17,955 | 0 | 13.5 K to 0 (-100.00 %) |
Dec 07 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.31 | 6,500 | 8,515 | 13,500 | 20 K to 13.5 K (-32.50 %) |
Dec 07 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.30 | 26,488 | 34,434 | 20,000 | 46.5 K to 20 K (-56.98 %) |
Dec 06 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.44 | 7,100 | 10,224 | 46,488 | 53.6 K to 46.5 K (-13.25 %) |
Dec 06 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.42 | 3,700 | 5,254 | 53,588 | 57.3 K to 53.6 K (-6.46 %) |
Dec 06 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.40 | 4,000 | 5,600 | 57,288 | 61.3 K to 57.3 K (-6.53 %) |
Dec 06 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.39 | 200 | 278 | 61,288 | 61.5 K to 61.3 K (-0.33 %) |
Nov 07 2005 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | EVP and COO | Buy | P | 1.52 | 9,900 | 15,048 | 90,294 | 80.4 K to 90.3 K (+12.31 %) |
Nov 09 2005 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | EVP and COO | Buy | P | 1.40 | 20,000 | 28,000 | 59,400 | 39.4 K to 59.4 K (+50.76 %) |
Nov 09 2005 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | EVP and COO | Buy | P | 1.50 | 10,000 | 15,000 | 39,400 | 29.4 K to 39.4 K (+34.01 %) |
Dec 05 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.45 | 6,500 | 9,425 | 61,488 | 68 K to 61.5 K (-9.56 %) |
Dec 05 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.43 | 3,600 | 5,148 | 67,988 | 71.6 K to 68 K (-5.03 %) |
Dec 05 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.42 | 7,900 | 11,218 | 71,588 | 79.5 K to 71.6 K (-9.94 %) |
Dec 05 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.41 | 2,000 | 2,820 | 79,488 | 81.5 K to 79.5 K (-2.45 %) |
Dec 05 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.52 | 1,300 | 1,976 | 81,488 | 82.8 K to 81.5 K (-1.57 %) |
Dec 05 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.51 | 1,900 | 2,869 | 82,788 | 84.7 K to 82.8 K (-2.24 %) |
Dec 05 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.50 | 800 | 1,200 | 84,688 | 85.5 K to 84.7 K (-0.94 %) |
Dec 05 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.48 | 1,200 | 1,776 | 85,488 | 86.7 K to 85.5 K (-1.38 %) |
Dec 05 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.47 | 500 | 735 | 86,688 | 87.2 K to 86.7 K (-0.57 %) |
Dec 05 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.46 | 800 | 1,168 | 87,188 | 88 K to 87.2 K (-0.91 %) |
Dec 05 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Sell | S | 1.44 | 300 | 432 | 87,988 | 88.3 K to 88 K (-0.34 %) |
Oct 04 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Option Exercise | M | 1.35 | 57,906 | 78,173 | 0 | |
Oct 04 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Buy | M | 1.35 | 57,906 | 78,173 | 88,288 | 30.4 K to 88.3 K (+190.59 %) |
Oct 17 2005 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Executive VP and CF ... | Buy | P | 1.70 | 8,200 | 13,940 | 71,780 | 63.6 K to 71.8 K (+12.90 %) |
Oct 17 2005 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Executive VP and CF ... | Buy | P | 1.68 | 100 | 168 | 63,580 | 63.5 K to 63.6 K (+0.16 %) |
Oct 17 2005 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Executive VP and CF ... | Buy | P | 1.65 | 14,900 | 24,585 | 63,480 | 48.6 K to 63.5 K (+30.67 %) |
Oct 17 2005 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Executive VP and CF ... | Buy | P | 1.64 | 800 | 1,312 | 48,580 | 47.8 K to 48.6 K (+1.67 %) |
Nov 03 2005 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President & CEO | Buy | P | 1.67 | 2,600 | 4,342 | 500,000 | 497.4 K to 500 K (+0.52 %) |
Nov 03 2005 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President & CEO | Buy | P | 1.66 | 914 | 1,517 | 497,400 | 496.5 K to 497.4 K (+0.18 %) |
Oct 26 2005 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Buy | P | 1.78 | 1,300 | 2,314 | 62,200 | 60.9 K to 62.2 K (+2.13 %) |
Oct 26 2005 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Buy | P | 1.75 | 3,000 | 5,250 | 60,900 | 57.9 K to 60.9 K (+5.18 %) |
Oct 26 2005 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Buy | P | 1.74 | 10,300 | 17,922 | 57,900 | 47.6 K to 57.9 K (+21.64 %) |
Oct 26 2005 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Buy | P | 1.71 | 1,000 | 1,710 | 47,600 | 46.6 K to 47.6 K (+2.15 %) |
Oct 26 2005 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Buy | P | 1.70 | 8,700 | 14,790 | 46,600 | 37.9 K to 46.6 K (+22.96 %) |
Oct 26 2005 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Buy | P | 1.69 | 100 | 169 | 37,900 | 37.8 K to 37.9 K (+0.26 %) |
Oct 26 2005 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Buy | P | 1.68 | 1,300 | 2,184 | 37,800 | 36.5 K to 37.8 K (+3.56 %) |
Oct 07 2005 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | Pres. & Chief Exec. ... | Buy | P | 1.69 | 800 | 1,352 | 496,486 | 495.7 K to 496.5 K (+0.16 %) |
Oct 07 2005 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | Pres. & Chief Exec. ... | Buy | P | 1.70 | 61,200 | 104,040 | 495,686 | 434.5 K to 495.7 K (+14.09 %) |
Aug 11 2005 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | A | 2.05 | 10,000 | 20,500 | 10,000 | |
Aug 11 2005 | TTNP | TITAN PHARMACEUTIC ... | CAVALLER EURELIO M | Director | Option Exercise | A | 2.05 | 15,000 | 30,750 | 15,000 | |
Aug 11 2005 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 2.05 | 15,000 | 30,750 | 15,000 | |
Aug 11 2005 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 2.05 | 10,000 | 20,500 | 10,000 | |
Aug 11 2005 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 2.05 | 15,000 | 30,750 | 15,000 | |
Aug 11 2005 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Option Exercise | A | 2.05 | 5,000 | 10,250 | 5,000 | |
Feb 09 2005 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec. VP and CFO | Option Exercise | A | 2.62 | 45,000 | 117,900 | 45,000 | |
Feb 09 2005 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Option Exercise | A | 2.62 | 100,000 | 262,000 | 100,000 | |
Feb 09 2005 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Exec. VP and COO | Option Exercise | A | 2.62 | 70,000 | 183,400 | 70,000 | |
Feb 09 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Option Exercise | A | 2.62 | 30,000 | 78,600 | 30,000 | |
Jan 07 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Option Exercise | M | 0.08 | 25,617 | 2,049 | 0 | |
Jan 07 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Buy | M | 0.08 | 25,617 | 2,049 | 30,382 | 4.8 K to 30.4 K (+537.61 %) |
Jan 07 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Option Exercise | M | 0.08 | 25,617 | 2,049 | 0 | |
Jan 07 2005 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Buy | M | 0.08 | 25,617 | 2,049 | 30,382 | 4.8 K to 30.4 K (+537.61 %) |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | AFTING ERNST GUNTER MD | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | CAVALLER EURELIO M | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | CAVALLER EURELIO M | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Sep 02 2004 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Option Exercise | A | 2.37 | 15,000 | 35,550 | 15,000 | |
Aug 18 2004 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Executive VP and CO ... | Buy | P | 2.20 | 2,500 | 5,500 | 180,394 | 177.9 K to 180.4 K (+1.41 %) |
Aug 18 2004 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Buy | P | 2.20 | 2,500 | 5,500 | 434,486 | 432 K to 434.5 K (+0.58 %) |
Aug 18 2004 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Sell | S | 2.20 | 5,000 | 11,000 | 8,644 | 13.6 K to 8.6 K (-36.65 %) |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 3.69 | 15,000 | 55,350 | 15,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | A | 3.69 | 10,000 | 36,900 | 10,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Option Exercise | A | 3.69 | 30,000 | 110,700 | 30,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | ALLEN RICHARD C | Executive Vice Pres ... | Option Exercise | A | 3.69 | 30,000 | 110,700 | 30,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 3.69 | 10,000 | 36,900 | 10,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | HSU MICHAEL | Director | Option Exercise | A | 3.69 | 5,000 | 18,450 | 5,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec VP & CFO | Option Exercise | A | 3.69 | 35,000 | 129,150 | 35,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec VP & CFO | Option Exercise | A | 3.69 | 35,000 | 129,150 | 35,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | CAVALLER EURELIO M | Director | Option Exercise | A | 3.69 | 10,000 | 36,900 | 10,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | CAVALLER EURELIO M | Director | Option Exercise | A | 3.69 | 10,000 | 36,900 | 10,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President & CEO | Option Exercise | A | 3.69 | 75,000 | 276,750 | 75,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President & CEO | Option Exercise | A | 3.69 | 5,000 | 18,450 | 5,000 | |
Feb 11 2004 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Option Exercise | M | 0.59 | 81,755 | 48,235 | 0 | |
Feb 11 2004 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Buy | M | 0.59 | 81,755 | 48,235 | 431,986 | 350.2 K to 432 K (+23.34 %) |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Exec. VP & COO | Option Exercise | A | 3.69 | 10,000 | 36,900 | 10,000 | |
Mar 11 2004 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Exec. VP & COO | Option Exercise | A | 3.69 | 50,000 | 184,500 | 50,000 | |
Dec 01 2003 | TTNP | TITAN PHARMACEUTIC ... | HSU MICHAEL | Director | Sell | S | 2.72 | 5,000 | 13,600 | 28,117 | 33.1 K to 28.1 K (-15.10 %) |
Nov 25 2003 | TTNP | TITAN PHARMACEUTIC ... | HSU MICHAEL | Director | Sell | S | 2.81 | 8,400 | 23,567 | 33,117 | 41.5 K to 33.1 K (-20.23 %) |
Nov 25 2003 | TTNP | TITAN PHARMACEUTIC ... | HSU MICHAEL | Director | Sell | S | 2.80 | 2,100 | 5,880 | 41,517 | 43.6 K to 41.5 K (-4.81 %) |
Nov 20 2003 | TTNP | TITAN PHARMACEUTIC ... | HSU MICHAEL | Director | Sell | S | 2.90 | 9,500 | 27,550 | 43,167 | 52.7 K to 43.2 K (-18.04 %) |